Endocrinology Test
|
|
| 1. In Europe, first-line treatment option in Graves’ disease is: |
|
|
| 2. The following is false regarding nonfunctional pituitary adenoma: |
|
|
| 3. The medical treatment in microprolactinomas: |
|
|
| 4. The most common cause of primary hyperaldosteronism is represented by: |
|
|
| 5. The acute treatment of tetany is made with: |
|
|
| 6. Testosterone has the following effects in men: |
|
|
| 7. Additional lab diagnostic in Cushing disease show: |
|
|
| 8. In pituitary tumors with compression of the cavernous sinus: |
|
|
| 9. Which statements regarding differentiated thyroid cancer are true: |
|
|
| 10. Which are true regarding calcitonin: |
|
|
| 11. In hypothyroid pregnant women the following are true: |
|
|
| 12. Conditions associated with thyrotoxicosis are: |
|
|
| 13. Laboratory exam in Graves’ disease shows: |
|
|
| 14. In case of Cushing disease the clinical picture: |
|
|
| 15. In cortisol –secreting adrenal adenoma: |
|
|
| 16. The complications of corticotherapy are: |
|
|
| 17. The endocrine complications of corticotherapy are: |
|
|
| 18. The clinical picture in chronic primary adrenal insufficiency includes: |
|
|
| 19. Laboratory tests for positive diagnosis in pheocromocytoma can reveal: |
|
|
| 20. Laboratory exam in global pituitary insufficiency shows: |
|
|
| 21. Bone formation agents used as osteoporosis treatment are represented by: |
|
|
| 22. In primary hypothyroidism laboratory investigations can reveal: |
|
|
| 23. Immunological evaluation of thyroid diseases comprise: |
|
|
| 24. FSH has the following effects in ovaries: |
|
|
| 25. Hormonal secretion regulation includes: |
|